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Background
==========

The tubby-like proteins are defined by a highly conserved carboxyl terminal half of their primary sequence known as the tubby signature domain \[[@B1],[@B2]\]. This family of proteins includes the prototype tubby, and TULP1, 2 and 3, for tubby-like proteins 1, 2 and 3 \[[@B3]-[@B5]\]. Other than members of the tubby family, search of sequence databases reveals no significant homology with known proteins or functional motifs. The tubby gene (*Tub*) was originally discovered by way of a spontaneously arisen obesity model in mice, and other members of the family were subsequently identified by homology cloning \[[@B3]\]. Mutations in human *TULP1* are a cause of retinitis pigmentosa \[[@B6]\]. Loss of TULP1 function in mice replicates this rapid photoreceptor degeneration phenotype \[[@B7],[@B8]\]. Prior to photoreceptor degeneration in the mouse retina, pronounced ectopic distribution of rhodopsin is apparent indicating a defect in trafficking across the connecting cilia to reach their normal destination, the outer segments \[[@B9]\]. Loss of TULP3 function in mice leads to neural tube patterning defects and embryonic lethality \[[@B10]\], and the cellular basis can be traced to a failure of Hedgehog signaling due to defective ciliary trafficking \[[@B11]\]. Little is known about *Tulp2*, but its Chlamydomonas ortholog was identified as one of strongly induced genes during flagellar regeneration \[[@B12]\] and it was also reported as a candidate gene for human obesity in linkage analysis \[[@B13]\]. The tubby signature domain binds polyphosphorylated phosphatidylinositol \[[@B14]\], but their N-terminal domain is much more diverse. In the best characterized example, the TULP3 N-terminal domain binds to the IFT-A complex, which is part of the essential cellular machinery for ciliary transport, through a short conserved motif. In cultured cells, TULP3 facilitates membrane receptor trafficking to primary cilia. Thus it serves as bipartite bridges through their phosphoinositide-binding tubby domain and N-terminal IFT-binding motif, coordinating multiple signaling pathways including membrane receptor trafficking \[[@B15]\].

Originally designated *rd5*\[[@B16]\], the spontaneously arisen *tubby* mouse mutant manifests retinal degeneration, hearing loss and obesity, a tripartite phenotype that resembles mouse models of Bardet-Biedl syndrome (BBS) \[[@B17],[@B18]\]. The *tubby* mutation is a G-to-T transversion that abolishes the donor splice site in the penultimate exon (exon 11), resulting in an aberrant transcript \[[@B19]\]. This leads to the substitution of the tubby C-terminal 44 amino acids with 24 different residues encoded by the intron. The spontaneous mutation in the *tubby* mouse (*Tub*^*tub/tub*^) appears to cause a loss of function, as targeted disruption of the *tub* gene gives a similar phenotype \[[@B20]\]. The original study on *tubby* mice found moderate and progressive hearing loss, and a moderate retinal degeneration \[[@B16]\]. A modifier gene *Mtap1a* modulates the severity of hearing loss and retinal degeneration in the *tubby* mutant mice \[[@B21],[@B22]\]. One interesting feature of the *tubby* mutant that is shared with the *Tulp1* knockout mouse is the extracellular accumulation of rhodopsin-laden vesicles in the interphotoreceptor space surrounding the photoreceptor inner segments, which peaks at around 17 to 21 days of age when rhodopsin is rapidly synthesized to build up the outer segments \[[@B16]\]. The vesicles are relatively uniform in size averaging 0.1 to 0.2 μm in diameter and bounded by a single membrane. This distinct phenotype is also seen in transgenic mice carrying a C-terminal rhodopsin mutation known to affect specifically the trafficking of rhodopsin to the outer segments \[[@B23]\]. It was, therefore, hypothesized that the extracellular vesicle accumulation might be a hallmark of defect in the directional transport of nascent rhodopsin to the outer segments, thus implying a role for tubby and TULP1 in rhodopsin trafficking in photoreceptors \[[@B9]\]. In further support of this hypothesis, mice doubly mutant for *tubby* and *Tulp1* have a much more severe retinal phenotype than either mutant alone, manifesting a complete failure of rhodopsin trafficking and outer segment formation, and rapid cell death. These data would appear to suggest that tubby may function synergistically with TULP1 in a pathway that facilitates rhodopsin trafficking to the outer segments \[[@B9]\]. Differing from TULP1*,* which is photoreceptor-specific, tubby has a wider range of expression but appears enriched in neuronal tissues.

Based on a structure-directed approach, it has been proposed that tubby-like proteins are a unique family of bipartite transcription factors \[[@B14],[@B24]\]. The molecular architecture of tubby-like proteins is seen as well suited for a function in transcriptional modulation. There is the nuclear localization signal at the N terminus of tubby, an ability of the N-terminal domain to activate transcription when fused to a DNA binding motif and the ability of the conserved C-terminal tubby domain to bind DNA and phosphatidylinositol 4, 5-bisphosphate (PIP~2~). That the tubby domain binds specifically to PIP~2~ has been well established \[[@B25]\] but the transcriptional target genes of tubby have remained unknown. In another series of studies, tubby was proposed to be a MerTK ligand that mediates phagocytosis of the photoreceptor outer segments by retinal pigment epithelia \[[@B26]\]. These findings represented advances in the molecular dissection of tubby function, but how they relate to the *in vivo* role of tubby and the *tubby* mutant phenotype has been less clear. In this study, we examined the subcellular distribution of a number GPCRs and show that tubby is essential for GPCR trafficking in the neuronal and sensory cilia.

Methods
=======

Animals
-------

All animal care and procedures were approved by Animal Care and Use Committees at the Dean A. McGee Eye Institute and the National Eye Institute. Mice were maintained in an animal facility under a 12-h light/12-h dark lighting cycle. Genotyping for *tubby* mutation was based on a published protocol \[[@B27]\]. WT and *tubby* mutant mice at 1 month of age were used for analysis of the brain tissue, and mice at 1 month and at 12 days were used to analyze the retinal tissues.

Generation of tubby antibody
----------------------------

A His-tagged fusion protein encompassing the N-terminal 200 amino acid residues of mouse tubby protein was expressed in *E. coli*, purified and used to generate a polyclonal antibody in rabbit. The antibody was affinity-purified.

Immunoblotting analysis
-----------------------

Mice were euthanized and their retinas and brain were dissected out. Tissues were homogenized in RIPA buffer, boiled in Laemmli buffer and separated on 10% SDS-PAGE gels. Proteins were blotted to polyvinylidene difluoride (PVDF) membrane by electrotransfer. After blocking with 5% non-fat milk, the membranes were incubated with primary antibodies overnight at room temperature. After washing, membranes were incubated with peroxidase-conjugated secondary antibodies. SuperSignal® West Pico Chemiluminescent Substrate (Thermo Fisher Scientific, Rockford, IL, USA) was used for detection. For normalization, protein samples were separated on standard SDS-PAGE and probed with an anti-actin antibody.

Immunofluorescence
------------------

For immunofluorescence, eyes were enucleated, placed in fixative and their anterior segments and lens were removed. Brains were placed directly in a fixative containing 2% paraformaldehyde in phosphate buffered saline (PBS) for a total duration of 1.5 to 2 hours. Tissues were embedded in 3% agarose and sectioned at 75-μm thickness using a vibratome. Sections were collected into PBS buffer and remained free floating for the duration of the immunostaining process. For staining neuronal primary cilia in the brain, tissue sections were subjected to heat antigen retrieval at 60°C in PBS overnight. Prior to incubating with primary antibodies, sections were exposed to 50 mM NaCNBH~3~ to quench background fluorescence and blocked in 5% goat serum/PBS. All antibody incubations were carried out for 16 to 24 hours at ambient temperature. Cell nuclei were counter stained blue by 4′,6-diamidino-2-phenylindole (DAPI). The sections were viewed and photographed on a laser scanning confocal microscope (model TCS SP2; Leica Microsystems, Wetzlar, Germany). Multiple consecutive focal planes (Z-stack), spaced at 0.5-μm intervals, were captured.

Primary antibodies used were anti-GRK1 (MA1-720, ABR), anti-RP1 (a gift of Dr. Eric Pierce), anti-ACIII (sc-588; Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-SSTR3 (ss-830, Biotrend Chemicals, Destin, FL, USA), anti-MCHR1 (sc- 5534; Santa Cruz Biotechnology), anti-Htr6 (NBP1-46557, Novus Biologicals, Littleton, CO, USA), anti-mOR28 (NB110-75089, Novus Biologicals) and anti-rootletin \[[@B28]\]. Secondary antibodies included Alexa Fluor 488-, 546- and 647- conjugated antibodies (Invitrogen, Grand Island, NY, USA), and Cy3-conjugated donkey anti-goat IgG and Cy3-conjugated donkey anti-rabbit IgG (Jackson ImmunoResearch Laboratories, Inc, West Grove, PA, USA).

RNA isolation, cDNA synthesis and real-time quantitative PCR (qPCR)
-------------------------------------------------------------------

Total RNA was isolated from age and genetic background-matched WT and *tubby* mouse brains (at one month of age) using the TRIZOL reagents (Life Technologies, Carlsbad, CA, USA). RNA concentration was measured with NanoDrop spectrophotometer (Thermo Scientific, Wilmington, DE, USA) at a wavelength of 260 nm. cDNA synthesis was primed with oligo (dT)~20~ using Invitrogen SuperScript First-Strand Synthesis System (Life Technologies, Carlsbad, CA, USA). qPCR was carried out on an ABI 7900HT system (Life Technologies). Predesigned TaqMan Gene Expression Assays were purchased from Life Technologies with the following assay IDs: *Sstr3*, Mm00436695_s1; *Mchr1*, Mm00653044_m1; Eif2s3y, Mm00468995_g1; *Hprt1*, Mm01318747_g1; Rps26, Mm02601831_g1; *Tuba1a*, Mm00846967_g1. PCR reactions were carried out in triplicate in two independent reactions for each gene assayed, and the mean value was used to calculate fold-change of *Sstr3* and *Mchr1* in *tubby* vs. WT tissues, after normalizing against the geometric mean of the four housekeeping genes used as internal controls (*Hprt1, Eif2s3y, Rsp26, Tuba1a*) \[[@B29]\]. The comparative C~T~ method (the 2~T~^-ΔΔC^ method) was used for analyzing qPCR data \[[@B30]\].

Results
=======

Mislocalization of rhodopsin and cone opsin in the *tubby* mice
---------------------------------------------------------------

The aberrant *tubby* transcript is expressed at elevated levels in *tubby* mice \[[@B19]\]. To examine if any truncated forms of tubby protein may be expressed which may act dominantly and to compare the relative expression levels between different neural tissues, we generated a polyclonal antibody targeting the unique N-terminal domain of tubby and performed immunoblotting analysis of wild type (WT) and *tubby* mouse retina and brain extracts. As shown in Figure [1](#F1){ref-type="fig"}A, a prominent band at approximately 60 KDa was detectable in WT but not *tubby* mutant retina extracts. Similarly, a dominant band is detectable in the WT brain but absent in the mutant brain extract. No truncated form of tubby was found in the mutant tissue extracts. Since the tubby antibody targets the N-terminal domain and, therefore, would have been able to detect any truncated form of tubby, this observation indicates that the *tubby* mutation destabilizes the protein and behaves as a *null* allele. This finding largely replicates the result of a previous study \[[@B20]\]. Comparison with the actin loading control suggests that tubby is present in the retina at a much higher level than in the brain. Furthermore, tubby seems to be expressed as several variants as indicated by the broad banding pattern of the protein in the retina. The major brain tubby variant is of a larger size than that of the retina. The functional significance of this is currently unknown.

![**Immunofluorescence analyses of the*tubby*mutant retina. (A)** The WT tubby protein migrates at approximately 60 kDa by immunoblotting, but tubby protein expression is absent in the mutant tissues indicating that the mutation is a functional *null* allele. The lower panel shows the actin immunoblotting results as a loading control. **(B)** Rhodopsin is localized primarily in photoreceptor outer segments in WT but is severely mislocalized to the cell body in the *tubby* mutant at one month of age. Similarly, blue and green cone opsins are normally localized to the cone outer segments in WT but are also mislocalized to the cell body and synaptic terminals in the *tubby* mutant retina. **(C)** In contrast to rhodopsin and cone opsins, peripherin/RDS and GRK, which are also integral membrane proteins, do not show mislocalization in the *tubby* mutant. Rod PDE and RP1 protein, which are membrane and cytoskeleton associated proteins, respectively, also manifest normal outer segment localization. IS, inner segment; ONL, outer (photoreceptor) nuclear layer; OPL, outer plexiform layer; OS, outer segment. Cell nuclei were counter stained blue by DAPI.](2046-2530-1-21-1){#F1}

The photoreceptor outer segment is a modified cilium, where the visual pigment rhodopsin, a G protein-coupled receptor and other components of the phototransduction cascade are concentrated. The proximal end of the outer segment is linked to the cell body (inner segment) via a connecting cilium which is structurally homologous to the transition zone of motile or primary cilia \[[@B31]\] (Figure [1](#F1){ref-type="fig"}B). We assessed outer segment protein trafficking in the *tubby* mutant retina. Previously, we have suggested that tubby may function similarly to TULP1 in facilitating rod and cone opsin trafficking \[[@B7],[@B9]\], based on the phenotype of the double *tubby/Tulp1* mutant mice. In the present study, we assessed the rod and cone visual pigments localization in photoreceptors. As shown in Figure [1](#F1){ref-type="fig"}B, rhodopsin and cone opsins, the visual pigments in cone photoreceptors, in WT retina are normally localized exclusively in the outer segments. In the mutant, however, a substantial fraction of rhodopsin is mislocalized in the inner segments and cell bodies. Similarly, the cone opsins are also partially distributed in the inner segments, the perinuclear region and the synaptic terminals. Because of its abundance in the outer segments, the visual pigment is also a structural constituent of the outer segments. Decreased transport of the visual pigment likely explains the outer segments being shorter in the mutant. Retention of rhodopsin and most outer segment proteins in the cell body could be a secondary phenomenon to the advanced stage of photoreceptor degeneration. To gain further evidence that visual pigment mislocalization was a primary defect, we expanded our studies to include mutant retinas at postnatal Day 12 and found that opsin is similarly mislocalized (data not shown). In contrast to the mislocalization of the rhodopsin and cone opsins, which are 7-pass transmembrane GPCRs, the localization of non-GPCR membrane proteins, such as peripherin/RDS and rhodopsin kinase (GRK), appear unaffected (Figure [1](#F1){ref-type="fig"}C). Other membrane associated proteins, such as PDE, and cytoskeleton associated protein, such as RP1, are also unaffected (Figure [1](#F1){ref-type="fig"}C). These data suggest that transciliary protein trafficking is not generally defective in the *tubby* mutant. Thus the *tubby* mutation appears to retard rhodopsin traffic through the connecting cilium. The retinal phenotype of *tubby* mutant is similar to that of the *Tulp1* mutant mice although somewhat milder.

Lack of ciliary localization of neuronal GPCR in the brain of *tubby* mice
--------------------------------------------------------------------------

Primary cilia present on the central nervous system (CNS) neurons function as signaling organelles. Signaling cascades are activated upon stimulation of G protein coupled receptors that activate adenylate cyclase type III (ACIII). The latter is also concentrated in the primary cilia. ACIII activation increases production of cAMP, which serves as a second messenger to mediate a diverse array of cellular processes. To our knowledge, at least three GPCRs have been shown to concentrate at the plasma membrane of the cilia in the brain, namely MCHR1, SSTR3 and serotonin receptor 6 (5HT6 receptor) \[[@B32]-[@B34]\]. We, therefore, set out to examine if cilia-directed trafficking of these receptors is compromised in the *tubby* mutant. In pilot studies, we were not able to label 5HT6 in neuronal cilia; hence, we focused our efforts on MCHR1 and SSTR3. We first assessed if lack of tubby caused a failure of ciliogenesis, that is, failure of the cilia to emerge as has been shown in a number of other mouse models of ciliopathy. The ependymal epithelia lining the brain ventricles are multi-ciliated. These motile cilia are anchored to ciliary rootlets, composed of rootletin, as in all types of cilia \[[@B28],[@B35]\] (Figure [2](#F2){ref-type="fig"}A). By labeling with α-acetylated tubulin, we show comparable abundance and appearance of motile cilia (Figure [2](#F2){ref-type="fig"}B). We then used ACIII as a membrane protein marker for neuronal cilia \[[@B36]\]. As shown in Figure [2](#F2){ref-type="fig"}C, in two select regions of the mouse brain, the hippocampus and hypothalamus, ACIII clearly delineated the elongated primary cilia. Thus loss of tubby function does not appear to cause a generalized failure in ciliogenesis/maintenance, nor does it affect membrane protein trafficking to the cilia in general.

![**Normal ciliogenesis and correct non-GPCR membrane protein trafficking in*tubby*mutant. (A)** The ependymal epithelia lining the lateral ventricles of WT mouse brain are multiciliated. These cilia are anchored by the ciliary rootlets. The ciliary axonemes are stained with an α-acetylated tubulin antibody (red) and the rootlets are highlighted by staining for rootletin (green). The upper image shows a schematic diagram and the lower image shows actual immunofluorescence. **(B)** In both WT and mutant tissues, ependymal epithelia appear to develop cilia of comparable length, abundance and organization. The ciliary rootlets (green) appear as a patch beneath the cilia as they are not resolved individually. **(C)** Neuronal primary cilia in the CA1 hippocampus and the paraventricular hypothalamus are visualized by staining for ACIII (green). Rootletin (red) serves as a marker for the ciliary base. In both regions, the appearance of ACIII staining pattern is similar between the WT and *tubby* mutant. Cell nuclei were counter stained by DAPI (blue).](2046-2530-1-21-2){#F2}

We next validated the ciliary localization of the GPCRs in the neuronal cilia that has been reported in the literature. As shown in Figure [3](#F3){ref-type="fig"}, MCHR1 and SSTR3 were both detected in the neuronal cilia in the hypothalamus region of the WT mice. Within the hypothalamus, SSTR3 was particularly prominent in the ventromedial and arcuate regions, while MCHR1 was primarily found in the paraventricular region, in agreement with the expression of *tubby* mRNA in hypothalamus \[[@B19]\]. Both receptors were also detected in many areas of the brain. In the hippocampus, MCHR1 and SSTR3 appeared in a complementary pattern with MCHR1, being particularly strong in CA1 but weak in CA3, and SSTR3 displaying the opposite pattern (data not shown). These data confirm the previously published finding that these GPCRs are concentrated in the neuronal primary cilia.

![**SSTR3 and MCHR1 receptors in primary cilia of select brain regions. (A)** In the paraventricular hypothalamus region of the WT mouse brain, MCHR1 is seen concentrated in the neuronal cilia (red). **(B)** In the ventromedial hypothalamus region of the WT mouse brain, SSTR3 (green) is present in the neuronal primary cilia, thus validating the antibodies and the presence of these GPCRs in the cilia. Cell nuclei were counter stained blue by DAPI.](2046-2530-1-21-3){#F3}

We then compared the WT and the *tubby* mouse brains with respect to GPCR localization to the cilia. As shown in Figure [4](#F4){ref-type="fig"}A,B, in both the hippocampus and the hypothalamus regions of the *tubby* brain, SSTR3 is essentially undetectable or greatly diminished. The intensity of SSTR3 labeling is not uniform and shows considerable variability among different brain regions. Aside from the CA3 region of the hippocampus, additional regions of the mouse brain, such as the retrosplenial cortex, pontine central gray and infralimic area, also appeared to manifest a higher level of SSTR3 expression in the cilia. These regions, therefore, were carefully examined and compared between the WT and *tubby* mutant tissues. In all instances, we found the *tubby* mutant to have lost SSTR3 labeling of the primary cilia (Figure [4](#F4){ref-type="fig"}C). These data suggest that the SSTR3 receptor trafficking to neuronal primary cilia is generally disrupted in the *tubby* mutant.

![**Defective ciliary targeting of SSTR3 in the*tubby*mutant.** In both hippocampus **(A)** and in the hypothalamus **(B)** of the WT brain, SSTR3 (green) labels neuronal cilia strongly in the WT tissues (upper panels) but largely fail to label the cilia in the mutant (lower panels). The retrosplenial cortex **(C)**, pontine central gray **(D)** and infralimbic area **(E)** are three other brain regions where SSTR3 labeling of the neuronal cilia could be readily detected in the WT mouse. In all these regions, SSTR3 appear absent in the mutant. Rootletin staining (red) serves as a marker for the ciliary base. Cell nuclei were counter stained blue by DAPI.](2046-2530-1-21-4){#F4}

We obtained similar findings for the MCHR1 receptor (Figure [5](#F5){ref-type="fig"}). In both the hippocampus (Figure [5](#F5){ref-type="fig"}A) and hypothalamus (Figure [5](#F5){ref-type="fig"}B), MCHR1 is specifically localized in the neuronal cilia of the WT mouse brain but it is largely absent from the *tubby* mutant. As shown in Figure [5](#F5){ref-type="fig"}, the loss of neuronal cilia labeling for MCHR1 in the mutant is not accompanied by an increased ectopic labeling for the protein, suggesting either that the protein is destabilized or that the level of dispersed receptor protein is below the threshold of detection in our assay.

![**Defective ciliary targeting of MCHR1 in the neuronal cilia of the*tubby*mutant.** MCHR1 (red) is found in neuronal cilia in WT (upper panels) but is lost from cilia in the mutant (lower panels) in both hippocampus **(A)** and in the hypothalamus **(B)**. Rootletin staining (green) serves as a marker for the ciliary base. Cell nuclei were stained (blue) with DAPI.](2046-2530-1-21-5){#F5}

As tubby could potentially serve as a transcriptional factor, an alternative explanation for the loss of receptors from the neuronal cilia could be a loss of transcription of those genes. We, therefore, investigated whether *Sstr3* and *Mchr1* mRNAs were absent or severely reduced in the *tubby* mouse brain. By reverse transcription and qPCR analysis, *Sstr3* mRNA in *tubby* appeared slightly higher than that of the WT, whereas *Mchr1* mRNA was found at approximately 60% of the WT levels (Figure [6](#F6){ref-type="fig"}). In neither case would loss of transcription appear to have taken place as a result of the *tubby* mutation, nor could that be an explanation for the disappearance of the receptors at the cilia.

![**Estimation of*Sstr3*and*Mchr1*transcript levels by qPCR.** Real time reverse transcription-quantitative PCR amplification of *Sstr3* and *Mchr1* mRNA from total brain RNA isolated from one pair of 20-day-old WT and *tubby* mutant mice using the TaqMan assay. Results shown are the means of triplicate assays from two independent RT-PCR experiments, normalized against the geometric mean of four genes that served as internal controls (*Hprt1, Eif2s3y, Rsp26, Tuba1a*). *Mchr1* and *Sstr3* transcripts are found at 62% and 115% of the WT levels, respectively.](2046-2530-1-21-6){#F6}

Role of tubby in the olfactory sensory epithelia
------------------------------------------------

The ciliated olfactory sensory neurons deploy a large repertoire of receptors, which are GPCRs, to their cilia for efficient sensing of environmental odorants. A previous study on *Bbs2* and *Bbs4* mutants has suggested that lack of these BBS proteins leads to a defect in the distribution odorant receptors in the olfactory cilia \[[@B37]\]. We examined if tubby might also be required for the ciliary targeting of odorant receptors. We isolated WT and *tubby* mutant olfactory epithelia and stained for mOR28, one of the odorant receptors, along with other ciliary markers. As shown in Figure [7](#F7){ref-type="fig"}, the development and maintenance of olfactory sensory cilia appear comparable between WT and the *tubby* mutant. In the mutant, the mOR28 receptor is distributed to the distal portion of the cilia in a manner that is indistinguishable from the WT, and there is no evidence that the receptor protein is ectopically retained within the cell body. These data suggest that tubby function appears dispensable for the correct trafficking of odorant receptors. Thus the repertoire of GPCRs that are critically dependent on BBS proteins for transciliary trafficking and those requiring tubby function appear to overlap but are not identical.

![**Odorant receptors are trafficked normally to the cilia of olfactory sensory neurons in*tubby*mice.** Localization of the odorant receptor mOR28 in the olfactory sensory cilia appears indistinguishable between WT and *tubby* mutant. **(A)** mOR28 (green) double labeled with α-acetylated tubulin (red) which highlight the ciliary axoneme. In both WT and mutant tissues, mOR28 appear localized to the cilia layer with weaker signal appearing in the neuronal soma in both genotypes. **(B)** mOR28 (green) double labeled with rootletin (red). In both WT and mutant tissues, mOR28 is localized distal to rootletin, as would be expected for a ciliary localization.](2046-2530-1-21-7){#F7}

Discussion
==========

In this study we show that in the absence of tubby, a number of 7-pass transmembrane proteins that function as GPCRs are not properly transported to the primary or sensory cilia. In the brain, we have demonstrated that tubby is required for the transciliary trafficking of two GPCRs, MCHR1 and SSTR3. In multiple brain regions where these GPCRs are found to concentrate in the cilia in WT mice, we show that the same GPCRs are diminished or extinguished from the neuronal primary cilia of *tubby* mice. By co-labeling with α-acetylated tubulin for ciliary axoneme and with the ciliary membrane protein ACIII, we show that ciliogenesis or maintenance appear unaffected in the *tubby* mutant. Therefore, the primary defect in the tubby *mutant* is a block in transport of select GPCRs to the neuronal primary cilia. Tubby is not essential for all GPCR trafficking in neuronal cilia, however. In our study, we found that the odorant receptor mOR28, which is a GPCR that interacts with odorant molecules, remains correctly localized to the distal cilia of olfactory epithelial cells. The entire repertoire of GPCRs that requires tubby protein for trafficking is unlikely to be limited to just MCHR1 and SSTR3. As more cilia restricted GPCRs in the brain are being discovered and tested in the *tubby* mutant, a more complete list of tubby-dependent GPCR will emerge, which in turn, may help define precisely how tubby functions in a ciliary trafficking pathway.

In the *tubby* mutant retina, photoreceptor cells accumulate rhodopsin and cone opsins ectopically in the cell body, accompanied by shortened outer segments. Mislocalization of rhodopsin can occur as a secondary phenomenon to retinal degeneration as discussed previously \[[@B9]\]. On the other hand, most retinal degeneration mouse models, in which the affected gene does not function in rhodopsin or ciliary trafficking, do not show overt opsin mislocalization when the photoreceptor layers are largely still intact. For example, in the rhodopsin T17M transgenic mice \[[@B9]\] and in the P23H transgenic mice and rats \[[@B38]-[@B40]\], opsin correctly localize to the outer segments. In contrast, in the rhodopsin P347S mutant, which affects a known C-terminal trafficking signal \[[@B41],[@B42]\], opsin is prominently mislocalized early on \[[@B23]\]. In the *tubby* mutant, opsin mislocalization is likely to be a primary defect since we observed rhodopsin mislocalization at an early time point (postnatal Days 12 and 30) while the photoreceptors are still relatively intact and when trafficking of most other membrane proteins remains normal. Furthermore, *tubby* mice accumulate extracellular vesicles at early postnatal ages which had been shown to be evidence of aberrant rhodopsin trafficking \[[@B9]\]. We believe, therefore, that rhodopsin mislocalization is a primary defect in the *tubby* mutant photoreceptor, much like that observed in the related *Tulp1* mutant mouse in previous studies \[[@B9]\]. The defect in the photoreceptors is limited to GPCRs, rather than a generalized failure of targeting proteins to the outer segments.

In the sensory hair cells of the cochleas, loss of tubby function apparently has a negative impact as well as indicated by the hearing loss in the *tubby* mice. We hypothesize that the primary defect in the cochlea hair cells might also originate from a defective protein trafficking along the kinocilia. It remains unclear, however, what GPCRs might be candidates for tubby-dependent transport machinery in cochlear hair cells.

Both the *tubby* mouse phenotype and the cellular defect described in this study appear remarkably similar to those found in the mouse models of BBS. Both models develop obesity, retinitis pigmentosa and hearing loss. Although human BBS patients often show polydactyly, neither mouse models do so, reflecting again the similarity of the two disease models. Human BBS also manifests mental retardation. In BBS2 and BBS4 mouse mutants, both SSTR3 and MCHR1 receptors were found to be absent from neuronal primary cilia \[[@B37]\]. MCHR1 mediated signaling in the hypothalamus regulates food intake and energy homeostasis \[[@B43]\], and the disruption of its normal localization in the cilia could underlie at least in part the obesity phenotype of the *tubby* mice. SSTR3 signaling in the cilia of hippocampal neurons appears to couple to ACIII. Disruption of somatostatin signaling in the hippocampus, as revealed in the study of *Sstr3* knockout mice, leads to lower cAMP levels in the hippocampus and a defect in novel object learning \[[@B44]\]. This phenotype is similar to that of ACIII knockout mice \[[@B45]\]. Many BBS proteins have been found to localize to the base of cilia. In the case of tubby like proteins, we have previously shown that TULP1 is diffusely distributed throughout the photoreceptor cell body \[[@B9]\]. We were unable to pinpoint tubby protein in the proximity of cilia either in photoreceptors or in CNS neurons (data not shown). A previous work by Ikeda *et al.* also found a diffuse pattern of tubby staining in the retina. Thus tubby and TULP1 seem to differ from TULP3, which localizes to the base or ciliary shaft in cultured cells \[[@B11],[@B15]\]. It is possible that tubby will behave differently in cultured neurons vs. *in vivo* tissues, or that tubby localizes to the cilia under specific conditions. Further experiments will be needed to clarify these points. A human disease attributable to a *tubby* mutation has not been identified, but BBS is a plausible candidate.

How tubby-like proteins perform their functions remain incompletely understood. Available data together indicate a role for tubby proteins at the cilia. In the case of tubby, TULP1 and TULP3, ciliary trafficking of GPCRs is likely to be a major aspect of their ciliary functions, whereas TULP2 has been implicated in ciliogenesis \[[@B12]\]. A recent study provides important insights into how tubby proteins may execute this process \[[@B1],[@B15]\]. In that study, it was found that TULP3 interacts with IFT-A particles to traffic membrane receptors to cilia, and modulation by phosphoinositide binding is also required for this process. Furthermore, the IFT-binding sequence in the divergent N-terminal domain is also present in tubby and TULP2, suggesting that other *tubby* family members may also interact with IFT-A. Thus, a functional interaction with IFT particles during ciliary trafficking may be generally applicable to mechanisms of action by tubby-like proteins. It remains to be determined how the ciliary trafficking role of tubby-like proteins might reconcile with the proposed transcription modulator model \[[@B14]\]. In that model, tubby associates with plasma membranes where PIP~2~ contents are high. Upon G protein signaling and hydrolysis of PIP~2~ by phospholipase C, tubby dissociates from plasma membrane and translocates to the nucleus where it binds DNA and modulates gene transcription. It is possible that tubby engages in a similar process, getting on and off plasma membranes depending on the phosphoinositide content along the route of ciliary trafficking. In this regard, it is interesting to note that PIP~2~ phosphatases, INPP5E and INPP5F, are localized in the cilia and their functional deficits are associated with ciliopathy \[[@B46]-[@B49]\], thus creating a potential gradient of PIP~2~ physiologically at the cilia-plasma membrane junction. As to whether and how tubby-like proteins modulate gene transcription or serve as a ligand for phagocytosis will await further studies.

Conclusions
===========

Tubby protein, and the tubby-like family of proteins in general, are involved in transciliary trafficking of select GPCRs. The GPCR trafficking defects we identified could largely explain the phenotype of the *tubby* mutant mice.
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